[ESPR] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
02-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 0.87%
YoY- -5.52%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 40,659 212,236 982 0 0 0 0 -
PBT -43,668 124,611 -54,221 -45,730 -43,337 -14,035 -12,395 23.33%
Tax 11,153 4,721 0 0 433 494 337 79.08%
NP -43,668 124,611 -54,221 -45,730 -43,337 -14,035 -12,395 23.33%
Tax Rate - -3.79% - - - - - -
Total Cost 84,327 87,625 55,203 45,730 43,337 14,035 12,395 37.61%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin -107.40 58.71 -5,521.49 0.00 0.00 0.00 0.00 -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -1.67 4.50 -2.01 -1.71 -1.92 -0.62 -0.55 20.31%
EPS Diluted -1.67 4.32 -2.01 -1.71 -1.92 -0.62 -0.55 20.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.